BROOKLYN IMMUNOTHERAPEUTICS (BTX)

US1140821000 - Common Stock

0.2051  +0 (+0.05%)

After market: 0.25 +0.04 (+21.89%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.005.80M19.81M23.34M
Cost Of Goods
N/AN/A2.91M7.48M8.07M
Gross Profit
N/AN/A2.89M12.32M15.27M
Operating Expenses
28.49M27.43M8.29M13.54M14.80M
Research and Development
9.26M12.71M2.00M26.00KN/A
Selling, General, and Administrative Expenses
18.41M14.72M6.09M13.15M14.49M
Operating Income
-28.49M-27.43M-5.40M-1.21M464.00K
Interest Income/Expense
-949.24K-74.00K-138.00K-249.00K-389.00K
Other Income/Expense
8.97M663.00K2.03M-9.00K-137.00K
Non Recurring Items
-86.99M-85.99M-910.00K-550.00K-261.00K
Income Before Taxes
-107.47M-122.48M-4.42M-2.02M-323.00K
Income Tax
N/A64.00K-6.00K27.00K-64.00K
Net Income
-107.53M-122.55M-4.42M-2.05M-259.00K
EBITDA
-28.34M-27.31M-3.66M1.67M3.23M
 
Per Share Data
EPS Diluted Total Ops
-2.10-2.83-3.02-1.42-0.19
Non GAAP EPS
-0.50N/AN/AN/A-0.04
 
Statistics
Gross Profit Margin
N/AN/A49.88%62.22%65.42%
Profit Margin
N/AN/A-76.12%-10.34%-1.11%
Operating Profit Margin
N/AN/A-93.09%-6.12%1.99%

All data in USD

Charts